Eupraxia Pharmaceuticals ($EPRX) Insider Trading & Smart Money Activity

Eupraxia Pharmaceuticals Inc. · Biotechnology · Latest filing Jun 26, 2026

Eupraxia Pharmaceuticals Inc. ($EPRX) has 2 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

EPRX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All EPRX insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 26, 2026	Analyst	Oppenheimer	Reiterates to buy		PT $17		-1.2%	-6.5%			Read
Jun 26, 2026	Analyst	Oppenheimer	Reiterates to buy		PT $17		-1.2%	-6.5%			Read

1W / 1M / 6M = how EPRX moved from the trade or filing date.

Analyst ratings on EPRX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 26, 2026	Oppenheimer	Reiterates	buy	$17	-1.2%	-6.5%		Read
Jun 26, 2026	Oppenheimer	Reiterates	buy	$17	-1.2%	-6.5%		Read

Other biotechnology stocks

• $AGMB
• $PRME
• $ALLO
• $ZVRA
• $PHAT
• $CBIO
• $DNA
• $ARVN

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.